Literature DB >> 1397035

Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience.

S E File1, N Andrews, P Y Wu, A Zharkovsky, H Zangrossi.   

Abstract

The purpose of the present experiment was to determine how a rat's prior history (of repeated gentle handling and/or of the elevated plus-maze apparatus) modified the behavioural and neurochemical response to chlordiazepoxide. In handled animals one previous exposure to the plus-maze rendered the rats insensitive to the anxiolytic effects of chlordiazepoxide in this test. This phenomenon of 'one-trial tolerance' was not seen in unhandled rats and thus both prior handling and prior maze experience were necessary to abolish the behavioural response to chlordiazepoxide. The effects of chlordiazepoxide on K(+)-evoked [14C]GABA (gamma-aminobutyric acid) release were also modified by the rat's past history. The drug-induced reduction of GABA release in the cortex was abolished by prior plus-maze experience; whereas handling modified chlordiazepoxide's effects on GABA release in the hippocampus (the drug decreased release in unhandled rats and increased release in those given repeated gentle handling). Thus an anxiolytic response to chlordiazepoxide in the plus-maze was accompanied by reduced GABA release in both cortex and hippocampus. The 5-HT system (5-hydroxytryptamine) also proved sensitive to the rats' past history. The effects of chlordiazepoxide on K(+)-evoked [3H]5-HT release from the hippocampus depended on both prior handling and plus-maze experience and could be predicted from the undrugged level of evoked release; when this was low, chlordiazepoxide increased it, when it was high, chlordiazepoxide reduced it. These results raise the possibility that the beneficial effects of a benzodiazepine may depend on the baseline condition of the animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1397035     DOI: 10.1016/0014-2999(92)90141-p

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Trial 2 in the elevated plus-maze: a different form of fear?

Authors:  S E File; H Zangrossi; M Viana; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  The use of the elevated plus maze as an assay of anxiety-related behavior in rodents.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  The four-plates test-retest paradigm to discriminate anxiolytic effects.

Authors:  Nadège Ripoll; Bríd Aine Nic Dhonnchadha; Véronique Sébille; Michel Bourin; Martine Hascoët
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

4.  "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

Authors:  S E File; H Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.

Authors:  Andrés P Varani; Ester Aso; Lirane Machado Moutinho; Rafael Maldonado; Graciela N Balerio
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

6.  Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

Authors:  R J Rodgers; J K Shepherd
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.

Authors:  B Costall; R J Naylor
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

8.  Sex differences in GABA/benzodiazepine receptor changes and corticosterone release after acute stress in rats.

Authors:  M A Wilson; R Biscardi
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

9.  Possible anxiolytic effects of ivermectin in rats.

Authors:  H de Souza Spinosa; S R A N Stilck; M M Bernardi
Journal:  Vet Res Commun       Date:  2002-06       Impact factor: 2.459

Review 10.  Preclinical animal anxiety research - flaws and prejudices.

Authors:  Abdelkader Ennaceur; Paul L Chazot
Journal:  Pharmacol Res Perspect       Date:  2016-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.